Novartis AG is 12.2x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($282.64 B vs $23.10 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | UTHR | NVS |
|---|---|---|
| Market cap | $23.10 B | $282.64 B |
| US-listed rank | #559 | #47 |
| Revenue (latest FY) | $3.18B | - |
| Net income (latest FY) | $1.33B | - |
| Net margin | 41.9% | - |
| P/E (trailing FY) | 17.3 | - |
| SEC filings | 4,203 | 947 |
Novartis AG is 12.2x more valuable than UNITED THERAPEUTICS Corp by market capitalization ($282.64 B vs $23.10 B).
Full pages: UNITED THERAPEUTICS Corp and Novartis AG, or browse the full rankings.